Software that uses AI to make cardiac-ultrasound experts of healthcare workers with no prior ultrasound experience has received “Breakthrough Device” designation from the FDA.

Worldwide, research is booming around AI applications for predicting and treating cancer with ever more precise and personalized approaches. However, a new literature review has found a shortfall of AI-inclusive studies looking at cancer outcomes and survivorship.

In a move closely partnering big pharma with big tech, Novartis and Microsoft have jointly announced a strategic alliance.

Leaders of HR departments are looking to AI for help improving the employee experience. As part of the effort, some 59% are considering or already adding virtual employee assistants like chatbots.

If a newly tested AI system for reading chest X-rays achieves widespread adoption, patients presenting in the ER with symptoms of pneumonia can expect an up or down diagnosis—and with it the start of a treatment plan—in 10 seconds.

If the researchers behind a new report on AI in healthcare are right, the technology could cut nonclinical workers’ workload by 40% while also slashing clinical tasks by 33%.

Researchers in Germany have developed an AI-based method for identifying pediatric acute appendicitis using biomarkers like blood and protein readings obtained in routine lab tests.

Engineers and roboticists in Europe have invented an artificial skin that can provide wearers with haptic feedback—replicating the human sense of touch—for potential applications in various fields, including medical rehabilitation and physical therapy. 

Several major charitable organizations are banding together to prevent 6 million deaths in 10 countries by 2030 using Big Data to provide precision medicine.

Aiming to develop and market AI algorithms for diagnosing prostate cancer on MRI scans, IBM Watson Health is working with Guerbet, a France-based maker of contrast agents used in medical imaging.